Serac Imaging Systems

The first clinical results using Seracam® for small organ imaging have been presented at European Association of Nuclear Medicine (EANM) Congress 2024 in Hamburg, Germany. The study involves a comparison of the diagnostic accuracy and resolution of radiopharmaceutical uptake between Seracam® and standard gamma cameras in a range of different procedures.   The e-poster submitted by Serac Imaging Systems’ clinical partners from the University of Malaya Medical Centre and Taylor's University, Malaysia includes case studies and images from a range of patients including parathyroid, lymphoscintigraphy and bone scan investigations.   The findings demonstrate that Seracam® is highly suited to small field-of-view imaging applications such as thyroid and parathyroid using Tc-99m and I-131; sentinel node localisation studies and bone spot views, among others.   For full details, please see the press release here: https://lnkd.in/gEgTgeuc   Intan Noorliyana Md Musidek, Aik Hao Ng, Chai Hong Yeong, Alan Perkins University of Malaya, Taylor's University, Hermes Medical Solutions #EANM24 #nuclearmedicine #smallorganimaging #medicalimaging #hybridimaging #thyroidimaging #lymphoscintigraphy  

Our CEO, Mark Rosser, will be heading off to Hamburg later this week to attend the annual European Association of Nuclear Medicine (EANM) congress taking place from 19-23 October. He will be available to discuss the latest developments with Seracam, including the first presentation of results from a small organ imaging study running in Malaysia, which will be presented in e-poster number EP-0715 throughout the conference. The abstract “SFoV Imaging Using a Hybrid Optical-Gamma Camera (HGC): Specifications and First Clinical Result” is accessible in the EANM ’24 Abstract book accessible until 7th November: https://lnkd.in/eKGB35vr And on our website here: https://lnkd.in/ewMry5yp Intan Noorliyana Md Musidek, Aik Hao Ng, Chai Hong Yeong, Alan Perkins University of Malaya, Taylor's University, Hermes Medical Solutions #EANM24 #nuclearmedicine #smallorganimaging #medicalimaging #hybridimaging #thyroidimaging

Our clinical partners from the University of Malaya today presented results from the first study evaluating Seracam in a surgical environment. The first user case in a clinical trial comparing the detection of sentinel lymph nodes in biopsy procedures in patients with breast cancer using Seracam® with standard gamma probe detection was presented in an oral presentation at the International Conference on Hybrid Imaging (IPET 2024) where the presenter Intan Noorliyana Md Musidek was selected for a ‘best of the best’ award. Based on these findings, the investigators have determined that Seracam® demonstrates clinical feasibility for sentinel lymph node imaging in breast cancer management. The study is ongoing. For full details please see the press release here: https://lnkd.in/e7CFDMdb The slide deck is available on request. Seracam® is for investigational use only and has not been cleared or approved by the FDA or UK and European regulatory authorities. #nuclearmedicine #hybridimaging #pointofcareimaging #smalloranimaging #breastcancer #sentinellymphnodebiopsy #IPET2024 Intan Noorliyana Md Musidek Aik Hao Ng Chai Hong Yeong Alan Perkins

Our CEO Mark Rosser will be joining this conference organised by the International Atomic Energy Agency (IAEA), taking place this week in Vienna. Intan Noorliyana Md Musidek from the Faculty of Medicine at the University of Malaya will be giving an oral presentation on the first results from a clinical trial running in Malaysia using our hybrid gamma-optical camera, Seracam®, in image guided surgery. The trial is comparing the detection of sentinel lymph nodes in biopsy procedures in patients with breast cancer with standard gamma probe detection. Seracam® is for investigational use only and has not been cleared or approved by the FDA or UK and European regulatory authorities. #nuclearmedicine #hybridimaging #pointofcareimaging #smalloranimaging #breastcancer #sentinellymphnodebiopsy #IPET2024

Great to see this write up by Tami Freeman in Physics World on the significance of the performance testing work on Seracam which was recently published in the European Journal of Nuclear Medicine and Molecular Imaging (EJNMMI), Physics. Thanks Sarah Bugby Loughborough University for clearly explaining the potential benefits of imaging with our compact, portable hybrid optical-gamma camera.   Seracam® is for investigational use only and has not been cleared or approved by the FDA or UK and European regulatory authorities. #medicalimaging  #diagnosticimaging #gammaimaging #hybridimaging #nuclearmedicine #molecularimaging #medicalinnovation #medicaltechnology

Our CEO Mark Rosser enjoyed updating journalist Shani Alexander from Bioworld Medtech recently about the ongoing clinical studies using Seracam at three international sites where encouraging results are being reported from studies in small organ imaging and sentinel lymph node biopsy. Subscribers can read the full article behind the paywall here: https://lnkd.in/gYfwMh6X Seracam® is for investigational use only and has not been cleared or approved by the FDA or UK and European regulatory authorities. #gammacamera #nuclearmedicine #hybridimaging #pointofcareimaging #thyroidimaging #smallorganimaging #breastcancer #sentinellymphnodebiopsy Clarivate for Life Sciences & Healthcare

Seracam’s performance characterisation results have been published for the first time by our academic partners at Loughborough University: “The results of this work clearly demonstrate that for SFOV [small field of view] imaging, Seracam offers the potential to extend the utility of nuclear medicine investigations beyond the restraints of the larger fixed camera systems.” Congratulations to Sarah Bugby and the team on this important publication. The open access article is available here: https://lnkd.in/eNPgeUC7 Seracam® is for investigational use only and has not been cleared or approved by the FDA or UK and European regulatory authorities. #medicalimaging #diagnosticimaging #gammaimaging #hybridimaging #nuclearmedicine #molecularimaging

We have received great news from our clinical partners running studies using Seracam at the University of Malaya Medical Centre. Dr Aik Hao Ng and his team are reporting encouraging early results using Seracam and have had abstracts accepted on the clinical evaluation of scans using the camera in both small organ imaging and image guided surgery at two prestigious meetings this autumn. Please see more details here: https://lnkd.in/eqMRd3_t Seracam® is for investigational use only and has not been cleared or approved by the FDA or UK and European regulatory authorities. European Association of Nuclear Medicine (EANM) International Atomic Energy Agency (IAEA) #nuclearmedicine #hybridimaging #pointofcareimaging #thyroidimaging #smallorganimaging #breastcancer #sentinellymphnodebiopsy  

Thank you Dr Aik Hao Ng for sharing these first images of Seracam in the operating theatre. We look forward to our continued work with you and the University Malaya Medical Centre team on this study.

Today saw the first ever use of Seracam® in image guided surgery. We are delighted to be working with the experienced and innovative clinical team at the University Malaya Medical Centre to assess the potential of Seracam’s real-time hybrid gamma-optical imaging to improve patient care in sentinel lymph node biopsy procedures for breast cancer. Please see more details here: https://lnkd.in/e8y8Xap8 Professor Alan Perkins, our scientific advisor and one of the original inventors of the camera is with Dr Aik Hao Ng, Professor See Mee Hoong and colleagues from the University of Malaya Medical Centre, to see this ground-breaking first use of Seracam in an operating theatre.   Seracam® is for investigational use only and has not been cleared or approved by the FDA or UK and European regulatory authorities.   #hybridimaging #molecularimaging #breastcancer #sentinellymphnodebiopsy #radioguidedsurgery #imageguidedsurgery #lymphoscintigraphy #SPECT